What are the major opportunities in the point-of-care molecular diagnostics market? What are the strategies for the point-of-care molecular diagnostics market?

For detailed insights on the major opportunities and strategies in the point-of-care molecular diagnostics market, Read More

How does the point-of-care molecular diagnostics market relate to the overall economy and other similar markets?

For detailed insights on point-of-care molecular diagnostics market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the point-of-care molecular diagnostics market growth? SWOT analysis of the point-of-care molecular diagnostics market.

For detailed insights on the key dynamics influencing the point-of-care molecular diagnostics market growth and SWOT analysis of the point-of-care molecular diagnostics industry, Read More

Point-Of-Care Molecular Diagnostics Market Report Infographic Image

Item added to cart!

Published : January 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Point-Of-Care Molecular Diagnostics Market Report 2026

Name: Point-Of-Care Molecular Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Assays And Kits, Instruments And Analyzers), By Application (Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), Bloodstream and Sepsis-Related Infections), By End-User (Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Point-Of-Care Molecular Diagnostics Market Overview

• Point-Of-Care Molecular Diagnostics market size has reached to $3.98 billion in 2025

• Expected to grow to $7.91 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%

• Growth Driver: Rising Incidence Of Infectious And Respiratory Diseases Fueling The Growth Of The Market Due To Increased Need For Rapid Diagnostics

• Market Trend: Next-Generation Poc Molecular Diagnostics Technologies Revolutionize Healthcare Industry

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Point-Of-Care Molecular Diagnostics Market?

Point-of-care (POC) molecular diagnostics refers to tests that detect the presence of specific nucleic acids in a clinical specimen, such as feces, saliva, urine, blood, and tissue. This molecular diagnostic is based on seeing targeted portions of microbial genetic material, DNA or RNA. It is utilized by the healthcare sector to detect emergency usage authorization to diagnose diseases. Point-of-care (POC) molecular diagnostic is used to detection of disease antigens or antibodies in human samples, such as mononucleosis, influenza, and group A streptococcus (GAS).

The main product and services of point-of-care molecular diagnostics are assays and kits, instruments and analyzers and software and services. Assays and kits refer to the equipment which is used in carrying out analyses such as studying disease pathways. Assays and kits were widely used for detecting rapid and accurate diagnosing and monitoring various diseases. Reverse transcription-polymerase chain reaction (RT-PCR), in situ-hybridization and sequencing are the technologies used in point-of-care molecular diagnostics that are used for diagnosis of diseases such as respiratory diseases, hospital-acquired infections (HAIs), cancer/oncology, hepatitis and hematologic. Decentralized labs, hospitals, home care, and assisted living healthcare facilities use point of care molecular diagnostics.

Point-Of-Care Molecular Diagnostics market report bar graph

What Is The Point-Of-Care Molecular Diagnostics Market Size and Share 2026?

The point-of-care molecular diagnostics market size has grown rapidly in recent years. It will grow from $3.98 billion in 2025 to $4.58 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, expansion of emergency diagnostic testing, rising demand for rapid clinical decision support, improvements in molecular assay technologies, growing use of poc diagnostics in hospitals.

What Is The Point-Of-Care Molecular Diagnostics Market Growth Forecast?

The point-of-care molecular diagnostics market size is expected to see rapid growth in the next few years. It will grow to $7.91 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to increasing adoption of home-based molecular testing, rising investments in rapid diagnostics infrastructure, expansion of respiratory and oncology testing applications, growing integration of cloud-based diagnostic platforms, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of rapid molecular testing platforms, rising demand for decentralized diagnostic solutions, growing integration of automated sample processing, expansion of syndromic testing panels, enhanced focus on fast turnaround times.

Book your 30 minutes free consultation with our research experts

Global Point-Of-Care Molecular Diagnostics Market Segmentation

1) By Product: Assays And Kits, Instruments And Analyzers

2) By Application: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), Bloodstream and Sepsis-Related Infections

3) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities

Subsegments:

1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables

2) By Instruments And Analyzers: Microfluidic Devices, Point-of-Care Analyzers

What Is The Driver Of The Point-Of-Care Molecular Diagnostics Market?

The rapid growth in the increasing occurrence of infectious and respiratory diseases is expected to significantly contribute to the growth of the point-of-care molecular diagnostics market. Respiratory infections, such as viruses or bacteria, are caused by microorganisms that influence the respiratory system. These microbes can be transferred through coughing, sneezing, or direct touch. The severity of the respiratory medications includes a variety of inhalers, oral medications, intravenous treatments, and point-of-care molecular diagnostic to cure the patient. For instance, in June 2024, according to the UK Health Security Agency, a UK-based government agency, between week 40 of 2022 and week 15 of 2023, 108 NHS trusts in England reported 1,681 critical care admissions for confirmed influenza. In comparison, the previous season saw 182 admissions across 114 trusts, increasing to 316 by week 39 of 2022. Therefore, the rapid occurrence of infectious and respiratory diseases and death will drive the point-of-care-molecular diagnostics market.

Key Players In The Global Point-Of-Care Molecular Diagnostics Market

Major companies operating in the point-of-care molecular diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, BioMérieux SA, Hologic Inc, Becton Dickinson and Company, Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc

Global Point-Of-Care Molecular Diagnostics Market Trends and Insights

Major companies operating in the point-of-care molecular diagnostics market are focused on providing technologically advanced solutions to strengthen their market position. These companies are implementing next-generation point-of-care molecular diagnostics technologies solutions and related services, such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, and others to implement on POC devices with features of accelerating analysis times and lowering costs. For instance, In May 2023, Sensible Diagnostics, a US-based diagnostics company, launched a 10-minute point-of-care PCR system. Sensible Diagnostics is utilizing the experience Curative has gained with its diagnostics business during the pandemic. The firm said it has run more than two million molecular point-of-care COVID-19 tests, and its PCR platform has a 10-minute time-to-result.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Point-Of-Care Molecular Diagnostics Market?

In July 2024, Roche Holding AG., a Switzerland-based global healthcare company that develops medicines, treatments, and diagnostics, acquired LumiraDx Ltd. for an undisclosed amount. With this acquisition, Roche Holding AG. aims to enhance its diagnostics portfolio, improve access to decentralized healthcare solutions, and expand testing capabilities, particularly in underserved regions. LumiraDx Ltd., a UK-based diagnostic company developing innovative point-of-care (POC) testing solutions.

Regional Outlook

North America was the largest region in the point-of-care molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Point-Of-Care Molecular Diagnostics Market?

The point-of-care (POC) molecular diagnostics market includes revenues earned by AAT, antigen, or antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Point-Of-Care Molecular Diagnostics Market Report 2026?

The point-of-care molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care molecular diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Point-Of-Care Molecular Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.58 billion
Revenue Forecast In 2035	$7.91 billion
Growth Rate	CAGR of 15.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Abbott Laboratories, F Hoffmann La Roche Ltd, BioMérieux SA, Hologic Inc, Becton Dickinson and Company, Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Point-Of-Care Molecular Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Point-Of-Care Molecular Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Point-Of-Care Molecular Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Point-Of-Care Molecular Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Adoption Of Rapid Molecular Testing Platforms

4.2.2 Rising Demand For Decentralized Diagnostic Solutions

4.2.3 Growing Integration Of Automated Sample Processing

4.2.4 Expansion Of Syndromic Testing Panels

4.2.5 Enhanced Focus On Fast Turnaround Times

5. Point-Of-Care Molecular Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Decentralized Laboratories

5.3 Home Care Providers

5.4 Assisted Living Healthcare Facilities

5.5 Diagnostic Clinics

6. Point-Of-Care Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point-Of-Care Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Point-Of-Care Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Point-Of-Care Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Point-Of-Care Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Point-Of-Care Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point-Of-Care Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point-Of-Care Molecular Diagnostics Market Segmentation

9.1. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Assays And Kits, Instruments And Analyzers

9.2. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), Bloodstream and Sepsis-Related Infections

9.3. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities

9.4. Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Assays And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables

9.5. Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Instruments And Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Microfluidic Devices, Point-of-Care Analyzers

10. Point-Of-Care Molecular Diagnostics Market Regional And Country Analysis

10.1. Global Point-Of-Care Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Point-Of-Care Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point-Of-Care Molecular Diagnostics Market

11.1. Asia-Pacific Point-Of-Care Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point-Of-Care Molecular Diagnostics Market

12.1. China Point-Of-Care Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point-Of-Care Molecular Diagnostics Market

13.1. India Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point-Of-Care Molecular Diagnostics Market

14.1. Japan Point-Of-Care Molecular Diagnostics Market Overview

14.2. Japan Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point-Of-Care Molecular Diagnostics Market

15.1. Australia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point-Of-Care Molecular Diagnostics Market

16.1. Indonesia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point-Of-Care Molecular Diagnostics Market

17.1. South Korea Point-Of-Care Molecular Diagnostics Market Overview

17.2. South Korea Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point-Of-Care Molecular Diagnostics Market

18.1. Taiwan Point-Of-Care Molecular Diagnostics Market Overview

18.2. Taiwan Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point-Of-Care Molecular Diagnostics Market

19.1. South East Asia Point-Of-Care Molecular Diagnostics Market Overview

19.2. South East Asia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point-Of-Care Molecular Diagnostics Market

20.1. Western Europe Point-Of-Care Molecular Diagnostics Market Overview

20.2. Western Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point-Of-Care Molecular Diagnostics Market

21.1. UK Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point-Of-Care Molecular Diagnostics Market

22.1. Germany Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point-Of-Care Molecular Diagnostics Market

23.1. France Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point-Of-Care Molecular Diagnostics Market

24.1. Italy Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point-Of-Care Molecular Diagnostics Market

25.1. Spain Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point-Of-Care Molecular Diagnostics Market

26.1. Eastern Europe Point-Of-Care Molecular Diagnostics Market Overview

26.2. Eastern Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point-Of-Care Molecular Diagnostics Market

27.1. Russia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point-Of-Care Molecular Diagnostics Market

28.1. North America Point-Of-Care Molecular Diagnostics Market Overview

28.2. North America Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point-Of-Care Molecular Diagnostics Market

29.1. USA Point-Of-Care Molecular Diagnostics Market Overview

29.2. USA Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point-Of-Care Molecular Diagnostics Market

30.1. Canada Point-Of-Care Molecular Diagnostics Market Overview

30.2. Canada Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point-Of-Care Molecular Diagnostics Market

31.1. South America Point-Of-Care Molecular Diagnostics Market Overview

31.2. South America Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point-Of-Care Molecular Diagnostics Market

32.1. Brazil Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point-Of-Care Molecular Diagnostics Market

33.1. Middle East Point-Of-Care Molecular Diagnostics Market Overview

33.2. Middle East Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point-Of-Care Molecular Diagnostics Market

34.1. Africa Point-Of-Care Molecular Diagnostics Market Overview

34.2. Africa Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point-Of-Care Molecular Diagnostics Market Regulatory and Investment Landscape

36. Point-Of-Care Molecular Diagnostics Market Competitive Landscape And Company Profiles

36.1. Point-Of-Care Molecular Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Point-Of-Care Molecular Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Point-Of-Care Molecular Diagnostics Market Company Profiles

36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F Hoffmann La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. BioMérieux SA Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Hologic Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Point-Of-Care Molecular Diagnostics Market Other Major And Innovative Companies

Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc

38. Global Point-Of-Care Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Point-Of-Care Molecular Diagnostics Market

40. Point-Of-Care Molecular Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Point-Of-Care Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Point-Of-Care Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Point-Of-Care Molecular Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Point-Of-Care Molecular Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Point-Of-Care Molecular Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Point-Of-Care Molecular Diagnostics Market, Supply Chain Analysis

Table 4: Global Point-Of-Care Molecular Diagnostics Market, Major Raw Material Providers

Table 5: Global Point-Of-Care Molecular Diagnostics Market, Major Resource Providers

Table 6: Global Point-Of-Care Molecular Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Point-Of-Care Molecular Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Point-Of-Care Molecular Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Point-Of-Care Molecular Diagnostics Market, Major Trends

Table 10: Global Point-Of-Care Molecular Diagnostics Market, Major End Users

Table 11: Global Point-Of-Care Molecular Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Point-Of-Care Molecular Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Point-Of-Care Molecular Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Point-Of-Care Molecular Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Assays And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Instruments And Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Point-Of-Care Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Point-Of-Care Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Point-Of-Care Molecular Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Point-Of-Care Molecular Diagnostics Market - Company Scoring Matrix

Table 96: Abbott Laboratories Financial Performance

Table 97: F Hoffmann La Roche Ltd Financial Performance

Table 98: BioMérieux SA Financial Performance

Table 99: Hologic Inc Financial Performance

Table 100: Becton Dickinson and Company Financial Performance

Table 101: Global Point-Of-Care Molecular Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 102: Global Point-Of-Care Molecular Diagnostics Market, Competitive Dashboard

Table 103: Global Point-Of-Care Molecular Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, Point-Of-Care Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 105: Global, Point-Of-Care Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 106: Global, Point-Of-Care Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Point-Of-Care Molecular Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Point-Of-Care Molecular Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Point-Of-Care Molecular Diagnostics Market, Supply Chain Analysis

Figure 4: Global Point-Of-Care Molecular Diagnostics Market, Major Raw Material Providers

Figure 5: Global Point-Of-Care Molecular Diagnostics Market, Major Resource Providers

Figure 6: Global Point-Of-Care Molecular Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Point-Of-Care Molecular Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Point-Of-Care Molecular Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Point-Of-Care Molecular Diagnostics Market, Major Trends

Figure 10: Global Point-Of-Care Molecular Diagnostics Market, Major End Users

Figure 11: Global Point-Of-Care Molecular Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Point-Of-Care Molecular Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Point-Of-Care Molecular Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Point-Of-Care Molecular Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Assays And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Instruments And Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Point-Of-Care Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Point-Of-Care Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Point-Of-Care Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Point-Of-Care Molecular Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Point-Of-Care Molecular Diagnostics Market - Company Scoring Matrix

Figure 96: Abbott Laboratories Financial Performance

Figure 97: F Hoffmann La Roche Ltd Financial Performance

Figure 98: BioMérieux SA Financial Performance

Figure 99: Hologic Inc Financial Performance

Figure 100: Becton Dickinson and Company Financial Performance

Figure 101: Global Point-Of-Care Molecular Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global Point-Of-Care Molecular Diagnostics Market, Competitive Dashboard

Figure 103: Global Point-Of-Care Molecular Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, Point-Of-Care Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 105: Global, Point-Of-Care Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 106: Global, Point-Of-Care Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Telemedicine Cart Market Forecast to Reach $4.03 Billion by 2029, Driven by 18.5% CAGR

Tendon Repair Industry Poised for Rapid Expansion, Projected to Hit $3.38 Billion by 2029

In-Depth Topical Absorbable Hemostats Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global 3D Bioprinting Market Projected to Reach $5.04 Billion by 2029 at a CAGR of 23.1%

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Explore strategic insights and forecasts in the global virtual biopsy market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Global Nuclear Reactor Market.

Molecular Diagnostics Devices And Equipment Market Report 2026 - Global Outlook – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA(Deoxyribonucleic acid) sequencing, Polymerase chain react...

Point of Care Diagnostics Market Report 2026 - Global Outlook – By Product (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy And Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monito...

Biomarker Clinical Phase Outsourcing Services Market Report 2026 - Global Outlook – By Type (Surrogate Endpoints, Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, Other Biomarker Types), By Service Type (Bio...

Colorectal Cancer Molecular Diagnostics Market Report 2026 - Global Outlook – By Type (Instruments, Reagents And Kits, Services), By Technology (Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcripti...

Dental Diagnostic Imaging Devices And Equipment Market Report 2026 - Global Outlook – By Method (Intraoral Imaging, Extraoral Imaging), By Technology (X-Ray Systems, Dental Cone Beam Computed Tomography, Optical Dental I...

Clinical Diagnostics Market Report 2026 - Global Outlook – By Test (Lab Test, Imaging Test, Other Tests), By Product (Instruments, Reagents, Other Products ), By End User (Hospital Laboratory, Diagnostic Laboratory, Poin...

Clinical Biomarkers Market Report 2026 - Global Outlook – By Offering (Product, Service), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immuno...

Frequently Asked Questions

What is the projected market size of the Point-Of-Care Molecular Diagnostics Market Report 2026 market by 2030?

The Point-Of-Care Molecular Diagnostics Market Report 2026 market was valued at $3.98 billion in 2025, increased to $4.58 billion in 2026, and is projected to reach $7.91 billion by 2030. request a sample here

What is the expected CAGR for the Point-Of-Care Molecular Diagnostics Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Point-Of-Care Molecular Diagnostics Market Report 2026 market during the forecast period 2025–2030 is 14.7%. request a sample here

What are the key factors driving the Point-Of-Care Molecular Diagnostics Market Report 2026 market?

Major growth driver of the market includes: Rising Incidence Of Infectious And Respiratory Diseases Fueling The Growth Of The Market Due To Increased Need For Rapid Diagnostics in the Point-Of-Care Molecular Diagnostics Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Point-Of-Care Molecular Diagnostics Market Report 2026 market report?

The point-of-care molecular diagnostics market covered in this report is segmented –
1) By Product: Assays And Kits, Instruments And Analyzers
2) By Application: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), Bloodstream and Sepsis-Related Infections
3) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities Subsegments:
1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables
2) By Instruments And Analyzers: Microfluidic Devices, Point-of-Care Analyzers request a sample here

What is the anticipated growth trend for the Point-Of-Care Molecular Diagnostics Market Report 2026 market?

Major trend in this market includes: Next-Generation Poc Molecular Diagnostics Technologies Revolutionize Healthcare Industry For further insights on this market, request a sample here.

Who are the key players in the Point-Of-Care Molecular Diagnostics Market Report 2026 market?

Major companies operating in the Point-Of-Care Molecular Diagnostics Market Report 2026 market are Major companies operating in the point-of-care molecular diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, BioMérieux SA, Hologic Inc, Becton Dickinson and Company, Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc request a sample here.

Which region has the most growth potential in the Point-Of-Care Molecular Diagnostics Market Report 2026 market?

North America was the largest region in the point-of-care molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.